Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-26T08:57:48.024Z Has data issue: false hasContentIssue false
  • English
  • Français

Essential tremor: genetic update

Published online by Cambridge University Press:  10 December 2019

Hao Deng Open the ORCID record for Hao Deng [Opens in a new window] ,
Shan Wu  and
Joseph Jankovic
Hao Deng*
Affiliation:
Center for Experimental Medicine, The Third Xiangya Hospital, Central South University, Changsha, China Department of Neurology, The Third Xiangya Hospital, Central South University, Changsha, China
Shan Wu
Affiliation:
Center for Experimental Medicine, The Third Xiangya Hospital, Central South University, Changsha, China
Joseph Jankovic
Affiliation:
Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, TX, USA
*
Author for correspondence: Hao Deng, E-mail: hdeng008@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Essential tremor (ET) is a neurological movement disorder characterised by bilateral limb kinetic/postural tremor, with or without tremor in other body parts including head, voice and lower limbs. Since no causative genes for ET have been identified, it is likely that the disorder occurs as a result of complex genetic factors interacting with various cellular and environmental factors that can result in abnormal function of circuitry involving the cerebello–thalamo–cortical pathway. Genetic analyses have uncovered at least 14 loci and 11 genes that are related to ET, as well as various risk or protective genetic factors. Limitations in ET genetic analyses include inconsistent disease definition, small sample size, varied ethnic backgrounds and many other factors that may contribute to paucity of relevant genetic data in ET. Genetic analyses, coupled with functional and animal studies, have led to better insights into possible pathogenic mechanisms underlying ET. These genetic studies may guide the future development of genetic testing and counselling, and specific, pathogenesis-targeted, therapeutic strategies.

Keywords

Animal modeldisease-causing mutationessential tremorgenetic locusrisk factor
Type
Unsolicited Review
Information
Expert Reviews in Molecular Medicine , Volume 21 , 2019 , e8
Copyright
Copyright © Cambridge University Press 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

The first two authors contributed equally to this study.

References

1.Haubenberger, D and Hallett, M (2018) Essential tremor. The New England Journal of Medicine 378, 1802–1810.CrossRefGoogle ScholarPubMed
2.Kuhlenbäumer, G, Hopfner, F and Deuschl, G (2014) Genetics of essential tremor: meta-analysis and review. Neurology 82, 1000–1007.CrossRefGoogle ScholarPubMed
3.Deuschl, G et al. (1998) Consensus statement of the Movement Disorder Society on tremor. Movement Disorders 13, 2–23.CrossRefGoogle ScholarPubMed
4.Bhatia, KP et al. (2018) Consensus statement on the classification of tremors. From the Task Force on Tremor of the International Parkinson and Movement Disorder Society. Movement Disorders 33, 75–87.CrossRefGoogle ScholarPubMed
5.Tarakad, A and Jankovic, J (2019) Essential tremor and Parkinson's disease: exploring the relationship. Tremor and Other Hyperkinetic Movements 8, 589.Google ScholarPubMed
6.Yuan, L et al. (2016) Genetic analysis of FGF20 variants in Chinese Han patients with essential tremor. Neuroscience Letters 620, 159–162.CrossRefGoogle ScholarPubMed
7.Louis, ED et al. (2007) Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 130, 3297–3307.CrossRefGoogle ScholarPubMed
8.Sullivan, KL, Hauser, RA and Zesiewicz, TA (2004) Essential tremor. Epidemiology, diagnosis, and treatment. The Neurologist 10, 250–258.CrossRefGoogle Scholar
9.Louis, ED (2001) Etiology of essential tremor: should we be searching for environmental causes? Movement Disorders 16, 822–829.CrossRefGoogle ScholarPubMed
10.Tanner, CM et al. (2001) Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology 57, 1389–1391.CrossRefGoogle ScholarPubMed
11.Deng, H, Le, W and Jankovic, J (2007) Genetics of essential tremor. Brain 130, 1456–1464.CrossRefGoogle ScholarPubMed
12.Leng, XR et al. (2017) Gain-of-function mutation p.Arg225Cys in SCN11A causes familial episodic pain and contributes to essential tremor. Journal of Human Genetics 62, 641–646.CrossRefGoogle ScholarPubMed
13.Liu, X et al. (2016) Identification of candidate genes for familial early-onset essential tremor. European Journal of Human Genetics 24, 1009–1015.CrossRefGoogle ScholarPubMed
14.Jiménez-Jiménez, FJ et al. (2016) A family study of DRD3 rs6280, SLC1A2 rs3794087 and MAPT rs1052553 variants in essential tremor. Neurological Research 38, 880–887.CrossRefGoogle ScholarPubMed
15.Müller, SH et al. (2016) Genome-wide association study in essential tremor identifies three new loci. Brain 139, 3163–3169.CrossRefGoogle ScholarPubMed
16.Naranjo, KV et al. (2018) Genetic testing preferences of individuals in families with essential tremor. Tremor and Other Hyperkinetic Movements 8, 545.Google ScholarPubMed
17.Gulcher, J et al. (1997) Mapping of a familial essential tremor gene, FET1, to chromosome 3q13. Nature Genetics 17, 84–87.CrossRefGoogle ScholarPubMed
18.Testa, CM (2013) Key issues in essential tremor genetics research: where are we now and how can we move forward? Tremor and Other Hyperkinetic Movements 3, tre-03-105-1843-1.Google ScholarPubMed
19.Illarioshkin, SN et al. (2002) Molecular genetic analysis of essential tremor. Genetika 38, 1704–1709.Google ScholarPubMed
20.Jeanneteau, F et al. (2006) A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proceedings of the National Academy of Sciences of the USA 103, 10753–10758.CrossRefGoogle ScholarPubMed
21.García-Martín, E et al. (2009) Dopamine receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor. Movement Disorders 24, 1910–1915.CrossRefGoogle ScholarPubMed
22.Tan, EK et al. (2007) DRD3 variant and risk of essential tremor. Neurology 68, 790–791.CrossRefGoogle ScholarPubMed
23.Blair, MA et al. (2008) Reappraisal of the role of the DRD3 gene in essential tremor. Parkinsonism and Related Disorders 14, 471–475.CrossRefGoogle ScholarPubMed
24.Inashkina, I et al. (2008) Case-control study of patiets with essential tremor in Latvia. European Journal of Neurology 15, 988–990.CrossRefGoogle Scholar
25.Vitale, C et al. (2008) DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients. European Journal of Neurology 15, 985–987.CrossRefGoogle ScholarPubMed
26.Lorenz, D et al. (2009) Dopamine receptor D3 gene and essential tremor in large series of German, Danish and French patients. European Journal of Human Genetics 17, 766–773.CrossRefGoogle ScholarPubMed
27.Novelletto, A et al. (2011) Linkage exclusion in Italian families with hereditary essential tremor. European Journal of Neurology 18, e118–e120.CrossRefGoogle ScholarPubMed
28.Kovach, MJ et al. (2001) Genetic heterogeneity in autosomal dominant essential tremor. Genetics in Medicine 3, 197–199.CrossRefGoogle ScholarPubMed
29.Ma, S et al. (2006) Familial essential tremor with apparent autosomal dominant inheritance: should we also consider other inheritance modes? Movement Disorders 21, 1368–1374.CrossRefGoogle ScholarPubMed
30.Aridon, P et al. (2008) Further evidence of genetic heterogeneity in familial essential tremor. Parkinsonism and Related Disorders 14, 15–18.CrossRefGoogle ScholarPubMed
31.Diaz, J et al. (1995) Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience 65, 731–745.CrossRefGoogle ScholarPubMed
32.Lucotte, G et al. (2006) Linkage with the Ser9Gly DRD3 polymorphism in essential tremor families. Clinical Genetics 69, 437–440.CrossRefGoogle ScholarPubMed
33.Lerer, B et al. (2002) Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology 27, 105–119.CrossRefGoogle ScholarPubMed
34.Ryoo, HL, Pierrotti, D and Joyce, JN (1998) Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease. Movement Disorders 13, 788–797.CrossRefGoogle ScholarPubMed
35.Higgins, JJ, Pho, LT and Nee, LE (1997) A gene (ETM) for essential tremor maps to chromosome 2p22-p25. Movement Disorders 12, 859–864.CrossRefGoogle ScholarPubMed
36.Higgins, JJ et al. (1998) Evidence that a gene for essential tremor maps to chromosome 2p in four families. Movement Disorders 13, 972–977.CrossRefGoogle ScholarPubMed
37.Higgins, JJ et al. (2003) Haplotype analysis of the ETM2 locus in familial essential tremor. Neurogenetics 4, 185–189.CrossRefGoogle ScholarPubMed
38.Kim, JH et al. (2005) Frequent sequence variation at the ETM2 locus and its association with sporadic essential tremor in Korea. Movement Disorders 20, 1650–1653.CrossRefGoogle ScholarPubMed
39.Higgins, JJ et al. (2005) A variant in the HS1-BP3 gene is associated with familial essential tremor. Neurology 64, 417–421.CrossRefGoogle ScholarPubMed
40.Deng, H et al. (2005) Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease. Neurology 65, 651–652.CrossRefGoogle ScholarPubMed
41.Higgins, JJ et al. (2004) Haplotype analysis at the ETM2 locus in a Singaporean sample with familial essential tremor. Clinical Genetics 66, 353–357.CrossRefGoogle Scholar
42.Shatunov, A et al. (2006) Genomewide scans in North American families reveal genetic linkage of essential tremor to a region on chromosome 6p23. Brain 129, 2318–2331.CrossRefGoogle ScholarPubMed
43.Merner, ND et al. (2012) Exome sequencing identifies FUS mutations as a cause of essential tremor. American Journal of Human Genetics 91, 313–319.CrossRefGoogle ScholarPubMed
44.Mrózek, K, Karakousis, CP and Bloomfield, CD (1993) Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3. Cancer Research 53, 1670–1675.Google ScholarPubMed
45.Zheng, W et al. (2013) Genetic analysis of the fused in sarcoma gene in Chinese Han patients with essential tremor. Neurobiology of Aging 34, 2078.e3–2078.e4.CrossRefGoogle ScholarPubMed
46.Rajput, A et al. (2014) Identification of FUS p.R377W in essential tremor. European Journal of Neurology 21, 361–363.CrossRefGoogle ScholarPubMed
47.Parmalee, N et al. (2013) Genetic analysis of the FUS/TLS gene in essential tremor. European Journal of Neurology 20, 534–539.CrossRefGoogle ScholarPubMed
48.Ortega-Cubero, S et al. (2013) Fused in Sarcoma (FUS) gene mutations are not a frequent cause of essential tremor in Europeans. Neurobiology of Aging 34, 2441.e9–2441.e11.CrossRefGoogle Scholar
49.Hedera, P et al. (2013) FUS in familial essential tremor – The search for common causes is still on. Parkinsonism and Related Disorders 19, 818–820.CrossRefGoogle Scholar
50.Deng, H, Gao, K and Jankovic, J (2014) The role of FUS gene variants in neurodegenerative diseases. Nature Reviews Neurology 10, 337–348.CrossRefGoogle ScholarPubMed
51.Schmouth, JF, Dion, PA and Rouleau, GA (2014) Genetics of essential tremor: from phenotype to genes, insights from both human and mouse studies. Progress in Neurobiology 119-120, 1–19.CrossRefGoogle ScholarPubMed
52.Macerollo, A and Bhatia, KP (2013) FUS gene mutations cause essential tremor: a surprise but also confirms genetic heterogeneity of essential tremor. Movement Disorders 28, 290.CrossRefGoogle ScholarPubMed
53.Labbé, C et al. (2013) Investigating the role of FUS exonic variants in essential tremor. Parkinsonism and Related Disorders 19, 755–757.CrossRefGoogle ScholarPubMed
54.Tio, M et al. (2016) FUS-linked essential tremor associated with motor dysfunction in Drosophila. Human Genetics 135, 1223–1232.CrossRefGoogle ScholarPubMed
55.Armstrong, GA and Drapeau, P (2013) Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS. Human Molecular Genetics 22, 4282–4292.CrossRefGoogle Scholar
56.Kabashi, E et al. (2011) FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. PLoS Genetics 7, e1002214.CrossRefGoogle Scholar
57.Hicks, GG et al. (2000) Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nature Genetics 24, 175–179.CrossRefGoogle ScholarPubMed
58.Hor, H et al. (2015) Missense mutations in TENM4, a regulator of axon guidance and central myelination, cause essential tremor. Human Molecular Genetics 24, 5677–5686.CrossRefGoogle ScholarPubMed
59.Chao, YX et al. (2016) Essential tremor linked TENM4 mutation found in healthy Chinese individuals. Parkinsonism and Related Disorders 31, 139–140.CrossRefGoogle ScholarPubMed
60.Tucker, RP and Chiquet-Ehrismann, R (2006) Teneurins: a conserved family of transmembrane proteins involved in intercellular signaling during development. Developmental Biology 290, 237–245.CrossRefGoogle ScholarPubMed
61.Suzuki, N et al. (2012) Teneurin-4 is a novel regulator of oligodendrocyte differentiation and myelination of small-diameter axons in the CNS. Journal of Neuroscience 32, 11586–11599.CrossRefGoogle ScholarPubMed
62.Zhou, XH et al. (2003) The murine Ten-m/Odz genes show distinct but overlapping expression patterns during development and in adult brain. Gene Expression Patterns 3, 397–405.CrossRefGoogle ScholarPubMed
63.Mosca, TJ et al. (2012) Trans-synaptic Teneurin signalling in neuromuscular synapse organization and target choice. Nature 484, 237–241.CrossRefGoogle ScholarPubMed
64.Unal Gulsuner, H et al. (2014) Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease. Proceedings of the National Academy of Sciences of the USA 111, 18285–18290.CrossRefGoogle Scholar
65.He, YC et al. (2017) Mutation analysis of HTRA2 gene in Chinese familial essential tremor and familial Parkinson's disease. Parkinson's Disease 2017, 3217474.CrossRefGoogle ScholarPubMed
66.Tzoulis, C et al. (2015) HTRA2 p.G399S in Parkinson disease, essential tremor, and tremulous cervical dystonia. Proceedings of the National Academy of Sciences of the USA 112, E2268.CrossRefGoogle ScholarPubMed
67.Chao, YX et al. (2015) Mitochondrial serine protease HTRA2 gene mutation in Asians with coexistent essential tremor and Parkinson disease. Neurogenetics 16, 241–242.CrossRefGoogle ScholarPubMed
68.Gray, CW et al. (2000) Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. European Journal of Biochemistry 267, 5699–5710.CrossRefGoogle ScholarPubMed
69.Dagda, RK and Chu, CT (2009) Mitochondrial quality control: insights on how Parkinson's disease related genes PINK1, parkin, and Omi/HtrA2 interact to maintain mitochondrial homeostasis. Journal of Bioenergetics and Biomembranes 41, 473–479.CrossRefGoogle ScholarPubMed
70.Strauss, KM et al. (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Human Molecular Genetics 14, 2099–2111.CrossRefGoogle ScholarPubMed
71.Casadei, N et al. (2016) Mitochondrial defects and neurodegeneration in mice overexpressing wild-type or G399S mutant HtrA2. Human Molecular Genetics 25, 459–471.CrossRefGoogle ScholarPubMed
72.Bergareche, A et al. (2015) SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy. Human Molecular Genetics 24, 7111–7120.Google ScholarPubMed
73.Bennani-Baiti, IM et al. (1995) Physical linkage of the human growth hormone gene cluster and the skeletal muscle sodium channel α-subunit gene (SCN4A) on chromosome 17. Genomics 29, 647–652.CrossRefGoogle ScholarPubMed
74.Nicole, S and Fontaine, B (2015) Skeletal muscle sodium channelopathies. Current Opinion in Neurology 28, 508–514.CrossRefGoogle ScholarPubMed
75.Shaikh, AG et al. (2008) Hypothetical membrane mechanisms in essential tremor. Journal of Translational Medicine 6, 68.CrossRefGoogle ScholarPubMed
76.Sánchez, E et al. (2015) SORT1 mutation resulting in sortilin deficiency and p75(NTR) upregulation in a family with essential tremor. ASN Neuro 7, 1759091415598290.CrossRefGoogle Scholar
77.Musunuru, K et al. (2010) From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466, 714–719.CrossRefGoogle ScholarPubMed
78.Nykjaer, A et al. (2004) Sortilin is essential for proNGF-induced neuronal cell death. Nature 427, 843–848.CrossRefGoogle ScholarPubMed
79.Willnow, TE, Petersen, CM and Nykjaer, A (2008) VPS10P-domain receptors – regulators of neuronal viability and function. Nature Reviews Neuroscience 9, 899–909.CrossRefGoogle ScholarPubMed
80.Ogata, N and Ohishi, Y (2002) Molecular diversity of structure and function of the voltage-gated Na+ channels. Japanese Journal of Pharmacology 88, 365–377.CrossRefGoogle ScholarPubMed
81.Baker, MD et al. (2003) GTP-induced tetrodotoxin-resistant Na+ current regulates excitability in mouse and rat small diameter sensory neurones. Journal of Physiology 548, 373–382.CrossRefGoogle ScholarPubMed
82.Herzog, RI, Cummins, TR and Waxman, SG (2001) Persistent TTX-resistant Na+ current affects resting potential and response to depolarization in simulated spinal sensory neurons. Journal of Neurophysiology 86, 1351–1364.CrossRefGoogle ScholarPubMed
83.Robinson, LJ et al. (1994) Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene. Genomics 19, 350–357.CrossRefGoogle ScholarPubMed
84.de la Monte, SM et al. (2000) Role of aberrant nitric oxide synthase-3 expression in cerebrovascular degeneration and vascular-mediated injury in Alzheimer's disease. Annals of the New York Academy of Sciences 903, 61–71.CrossRefGoogle ScholarPubMed
85.Durrenberger, PF et al. (2012) Inflammatory pathways in Parkinson's disease; A BNE microarray study. Parkinson's Disease 2012, 214714.CrossRefGoogle ScholarPubMed
86.Salinas, M et al. (1997) New modulatory α subunits for mammalian Shab K+ channels. Journal of Biological Chemistry 272, 24371–24379.CrossRefGoogle ScholarPubMed
87.Ueda, A and Wu, CF (2006) Distinct frequency-dependent regulation of nerve terminal excitability and synaptic transmission by I A and I K potassium channels revealed by Drosophila shaker and Shab mutations. Journal of Neuroscience 26, 6238–6248.CrossRefGoogle ScholarPubMed
88.Kaplan, WD and Trout, WE 3rd (1969) The behavior of four neurological mutants of Drosophila. Genetics 61, 399–409.Google ScholarPubMed
89.Smith, P et al. (2018) A Drosophila model of essential tremor. Scientific Reports 8, 7664.CrossRefGoogle ScholarPubMed
90.Klein, A et al. (2004) Episodic ataxia type 1 with distal weakness: a novel manifestation of a potassium channelopathy. Neuropediatrics 35, 147–149.Google ScholarPubMed
91.Bekku, Y et al. (2003) Molecular cloning of Bral2, a novel brain-specific link protein, and immunohistochemical colocalization with brevican in perineuronal nets. Molecular and Cellular Neuroscience 24, 148–159.CrossRefGoogle ScholarPubMed
92.Gironell, A (2014) The GABA hypothesis in essential tremor: lights and shadows. Tremor and Other Hyperkinetic Movements 4, 254.Google ScholarPubMed
93.Li, X et al. (2013) The deubiquitination enzyme USP46 functions as a tumor suppressor by controlling PHLPP-dependent attenuation of Akt signaling in colon cancer. Oncogene 32, 471–478.CrossRefGoogle Scholar
94.Zhang, W et al. (2011) Lysine 92 amino acid residue of USP46, a gene associated with ‘behavioral despair’ in mice, influences the deubiquitinating enzyme activity. PLoS ONE 6, e26297.Google ScholarPubMed
95.Wu, YR et al. (2010) Ubiquitin specific proteases USP24 and USP40 and ubiquitin thiolesterase UCHL1 polymorphisms have synergic effect on the risk of Parkinson's disease among Taiwanese. Clinica Chimica Acta 411, 955–958.CrossRefGoogle ScholarPubMed
96.Kushima, I et al. (2010) Association study of ubiquitin-specific peptidase 46 (USP46) with bipolar disorder and schizophrenia in a Japanese population. Journal of Human Genetics 55, 133–136.CrossRefGoogle Scholar
97.Tomida, S et al. (2009) Usp46 is a quantitative trait gene regulating mouse immobile behavior in the tail suspension and forced swimming tests. Nature Genetics 41, 688–695.CrossRefGoogle ScholarPubMed
98.Imai, S et al. (2012) Ubiquitin-specific peptidase 46 (Usp46) regulates mouse immobile behavior in the tail suspension test through the GABAergic system. PLoS ONE 7, e39084.CrossRefGoogle ScholarPubMed
99.Helmich, RC et al. (2013) The pathophysiology of essential tremor and Parkinson's tremor. Current Neurology and Neuroscience Reports 13, 378.CrossRefGoogle ScholarPubMed
100.Yang, ZQ et al. (2008) Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels. Journal of Medicinal Chemistry 51, 6471–6477.CrossRefGoogle ScholarPubMed
101.Stefansson, H et al. (2009) Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nature Genetics 41, 277–279.CrossRefGoogle ScholarPubMed
102.Thier, S et al. (2010) LINGO1 polymorphisms are associated with essential tremor in Europeans. Movement Disorders 25, 717–723.CrossRefGoogle ScholarPubMed
103.Liang, H et al. (2013) Genetic analysis of the leucine-rich repeat and lg domain containing Nogo receptor-interacting protein 1 gene in essential tremor. Journal of Molecular Neuroscience 51, 403–407.CrossRefGoogle ScholarPubMed
104.Vilariño-Güell, C et al. (2010) LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism and Related Disorders 16, 109–111.CrossRefGoogle ScholarPubMed
105.Clark, LN et al. (2010) Replication of the LINGO1 gene association with essential tremor in a North American population. European Journal of Human Genetics 18, 838–843.CrossRefGoogle Scholar
106.Vilariño-Güell, C et al. (2010) LINGO1 and LINGO2 variants are associated with essential tremor and Parkinson disease. Neurogenetics 11, 401–408.CrossRefGoogle ScholarPubMed
107.Tan, EK et al. (2009) LINGO1 variant increases risk of familial essential tremor. Neurology 73, 1161–1162.CrossRefGoogle ScholarPubMed
108.Wu, YW et al. (2011) Analysis of Lingo1 variant in sporadic and familial essential tremor among Asians. Acta Neurologica Scandinavica 124, 264–268.CrossRefGoogle ScholarPubMed
109.Lorenzo-Betancor, O et al. (2011) Lack of association of LINGO1 rs9652490 and rs11856808 SNPs with familial essential tremor. European Journal of Neurology 18, 1085–1089.CrossRefGoogle ScholarPubMed
110.Alakbarzade, V et al. (2019) Copy number variation of LINGO1 in familial dystonic tremor. Neurology. Genetics 5, e307.CrossRefGoogle ScholarPubMed
111.Carim-Todd, L et al. (2003) LRRN6A/LERN1 (leucine-rich repeat neuronal protein 1), a novel gene with enriched expression in limbic system and neocortex. European Journal of Neuroscience 18, 3167–3182.CrossRefGoogle Scholar
112.Deng, H, Gu, S and Jankovic, J (2012) LINGO1 variants in essential tremor and Parkinson's disease. Acta Neurologica Scandinavica 125, 1–7.CrossRefGoogle ScholarPubMed
113.Llorens, F et al. (2008) Developmental analysis of Lingo-1/Lern1 protein expression in the mouse brain: interaction of its intracellular domain with Myt1l. Developmental Neurobiology 68, 521–541.CrossRefGoogle ScholarPubMed
114.Agúndez, JA et al. (2015) The potential of LINGO-1 as a therapeutic target for essential tremor. Expert Opinion on Therapeutic Targets 19, 1139–1148.CrossRefGoogle ScholarPubMed
115.Mi, S et al. (2007) LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nature Medicine 13, 1228–1233.CrossRefGoogle ScholarPubMed
116.Wu, YW et al. (2011) Lingo2 variants associated with essential tremor and Parkinson's disease. Human Genetics 129, 611–615.CrossRefGoogle ScholarPubMed
117.Haines, BP and Rigby, PW (2008) Expression of the Lingo/LERN gene family during mouse embryogenesis. Gene Expression Patterns 8, 79–86.CrossRefGoogle ScholarPubMed
118.Homma, S et al. (2009) Expression pattern of LRR and Ig domain-containing protein (LRRIG protein) in the early mouse embryo. Gene Expression Patterns 9, 1–26.CrossRefGoogle ScholarPubMed
119.Thier, S et al. (2012) Polymorphisms in the glial glutamate transporter SLC1A2 are associated with essential tremor. Neurology 79, 243–248.CrossRefGoogle ScholarPubMed
120.Tan, EK et al. (2013) SLC1A2 variant associated with essential tremor but not Parkinson disease in Chinese subjects. Neurology 80, 1618–1619.CrossRefGoogle Scholar
121.Li, X and Francke, U (1995) Assignment of the gene SLC1A2 coding for the human glutamate transporter EAAT2 to human chromosome 11 bands p13-p12. Cytogenetics and Cell Genetics 71, 212–213.CrossRefGoogle ScholarPubMed
122.Lee, M et al. (2014) Decreased EAAT2 protein expression in the essential tremor cerebellar cortex. Acta Neuropathologica Communications 2, 157.CrossRefGoogle ScholarPubMed
123.Tanaka, K et al. (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276, 1699–1702.CrossRefGoogle ScholarPubMed
124.Zhang, Y et al. (2017) Assessment of three new loci from genome-wide association study in essential tremor in Chinese population. Scientific Reports 7, 7981.CrossRefGoogle ScholarPubMed
125.Ingersoll, RG et al. (2010) Association between genes on chromosome 4p16 and non-syndromic oral clefts in four populations. European Journal of Human Genetics 18, 726–732.CrossRefGoogle ScholarPubMed
126.Xiao, B et al. (2017) GWAS-linked PPARGC1A variant in Asian patients with essential tremor. Brain 140, e24.CrossRefGoogle ScholarPubMed
127.Esterbauer, H et al. (1999) Human peroxisome proliferator activated receptor gamma coactivator 1 (PPARGC1) gene: cDNA sequence, genomic organization, chromosomal localization, and tissue expression. Genomics 62, 98–102.CrossRefGoogle ScholarPubMed
128.Lin, J et al. (2004) Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1α null mice. Cell 119, 121–135.CrossRefGoogle ScholarPubMed
129.Zheng, B et al. (2010) PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Science Translational Medicine 2, 52ra73.CrossRefGoogle ScholarPubMed
130.Weydt, P et al. (2006) Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1α in Huntington's disease neurodegeneration. Cell Metabolism 4, 349–362.CrossRefGoogle ScholarPubMed
131.Boecker, H (2013) Imaging the role of GABA in movement disorders. Current Neurology and Neuroscience Reports 13, 385.CrossRefGoogle ScholarPubMed
132.Lucas, EK et al. (2012) Developmental alterations in motor coordination and medium spiny neuron markers in mice lacking PGC-1α. PLoS ONE 7, e42878.CrossRefGoogle ScholarPubMed
133.Janssens, B et al. (2003) Assessment of the CTNNA3 gene encoding human αT-catenin regarding its involvement in dilated cardiomyopathy. Human Genetics 112, 227–236.CrossRefGoogle Scholar
134.Janssens, B et al. (2001) αT-catenin: a novel tissue-specific β-catenin-binding protein mediating strong cell-cell adhesion. Journal of Cell Science 114, 3177–3188.Google ScholarPubMed
135.Miyashita, A et al. (2007) Genetic association of CTNNA3 with late-onset Alzheimer's disease in females. Human Molecular Genetics 16, 2854–2869.CrossRefGoogle ScholarPubMed
136.LaRoia, H and Louis, ED (2011) Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence? Neuroepidemiology 37, 1–10.CrossRefGoogle ScholarPubMed
137.Benito-León, J, Louis, ED and Bermejo-Pareja, F (2009) Risk of incident Parkinson's disease and parkinsonism in essential tremor: a population based study. Journal of Neurology Neurosurgery and Psychiatry 80, 423–425.CrossRefGoogle ScholarPubMed
138.Tan, EK et al. (2000) Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology 54, 1195–1198.CrossRefGoogle ScholarPubMed
139.Skipper, L et al. (2005) Analysis of LRRK2 functional domains in nondominant Parkinson disease. Neurology 65, 1319–1321.CrossRefGoogle ScholarPubMed
140.Sazci, A, Ergul, E and Bayulkem, K (2004) Association of the C677T and A1298C polymorphisms of methylenetetrahydrofolate reductase gene in patients with essential tremor in Turkey. Movement Disorders 19, 1472–1476.CrossRefGoogle ScholarPubMed
141.Ayuso, P et al. (2015) Heme oxygenase 1 and 2 common genetic variants and risk for essential tremor. Medicine (Baltimore) 94, e968.CrossRefGoogle ScholarPubMed
142.Vilariño-Güell, C et al. (2011) MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology 76, 670–672.CrossRefGoogle ScholarPubMed
143.Ortega-Cubero, S et al. (2015) TREM2 R47H variant and risk of essential tremor: a cross-sectional international multicenter study. Parkinsonism and Related Disorders 21, 306–309.CrossRefGoogle ScholarPubMed
144.La Spada, AR et al. (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77–79.CrossRefGoogle ScholarPubMed
145.Jacquemont, S et al. (2004) Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291, 460–469.CrossRefGoogle Scholar
146.Málly, J, Baranyi, M and Vizi, ES (1996) Change in the concentrations of amino acids in CSF and serum of patients with essential tremor. Journal of Neural Transmission (Vienna) 103, 555–560.CrossRefGoogle ScholarPubMed
147.Mostile, G and Jankovic, J (2010) Alcohol in essential tremor and other movement disorders. Movement Disorders 25, 2274–2284.CrossRefGoogle ScholarPubMed
148.Jankovic, J (2009) Treatment of hyperkinetic movement disorders. Lancet Neurology 8, 844–856.CrossRefGoogle ScholarPubMed
149.Kralic, JE et al. (2005) Genetic essential tremor in γ-aminobutyric acidA receptor α1 subunit knockout mice. Journal of Clinical Investigation 115, 774–779.CrossRefGoogle ScholarPubMed
150.Jankovic, J and Noebels, JL (2005) Genetic mouse models of essential tremor: are they essential? Journal of Clinical Investigation 115, 584–586.CrossRefGoogle ScholarPubMed
151.Deng, H et al. (2006) Genetic analysis of the GABRA1 gene in patients with essential tremor. Neuroscience Letters 401, 16–19.CrossRefGoogle ScholarPubMed
152.Chiu, CS et al. (2005) GABA transporter deficiency causes tremor, ataxia, nervousness, and increased GABA-induced tonic conductance in cerebellum. Journal of Neuroscience 25, 3234–3245.CrossRefGoogle ScholarPubMed
153.Thier, S et al. (2011) GABAA receptor- and GABA transporter polymorphisms and risk for essential tremor. European Journal of Neurology 18, 1098–1100.CrossRefGoogle Scholar
154.Ohno, Y et al. (2015) Hcn1 is a tremorgenic genetic component in a rat model of essential tremor. PLoS ONE 10, e0123529.CrossRefGoogle Scholar
155.Biel, M et al. (2009) Hyperpolarization-activated cation channels: from genes to function. Physiological Reviews 89, 847–885.CrossRefGoogle Scholar
156.Meisler, MH et al. (2004) Allelic mutations of the sodium channel SCN8A reveal multiple cellular and physiological functions. Genetica 122, 37–45.CrossRefGoogle ScholarPubMed
157.Sharkey, LM et al. (2009) Evaluation of SCN8A as a candidate gene for autosomal dominant essential tremor. Parkinsonism and Related Disorders 15, 321–323.CrossRefGoogle ScholarPubMed
158.Kuo, SH et al. (2019) Current opinions and consensus for studying tremor in animal models. Cerebellum. doi: 10.1007/s12311-019-01037-1.CrossRefGoogle ScholarPubMed
159.White, JJ et al. (2016) Pathogenesis of severe ataxia and tremor without the typical signs of neurodegeneration. Neurobiology of Disease 86, 86–98.CrossRefGoogle ScholarPubMed
160.Türkmen, S et al. (2009) CA8 mutations cause a novel syndrome characterized by ataxia and mild mental retardation with predisposition to quadrupedal gait. PLoS Genetics 5, e1000487.CrossRefGoogle Scholar
161.Hedera, P, Cibulčík, F and Davis, TL (2013) Pharmacotherapy of essential tremor. Journal of Central Nervous System Disease 5, 43–55.CrossRefGoogle ScholarPubMed
162.Lorenz, D and Deuschl, G (2007) Update on pathogenesis and treatment of essential tremor. Current Opinion in Neurology 20, 447–452.CrossRefGoogle ScholarPubMed
163.Wharen, RE Jr et al. (2017) Thalamic DBS with a constant-current device in essential tremor: a controlled clinical trial. Parkinsonism and Related Disorders 40, 18–26.CrossRefGoogle ScholarPubMed
164.Huss, DS et al. (2015) Functional assessment and quality of life in essential tremor with bilateral or unilateral DBS and focused ultrasound thalamotomy. Movement Disorders 30, 1937–1943.CrossRefGoogle ScholarPubMed
165.Thanvi, B, Lo, N and Robinson, T (2006) Essential tremor-the most common movement disorder in older people. Age and Ageing 35, 344–349.CrossRefGoogle ScholarPubMed
166.Tan, EK and Schapira, AH (2008) Hunting for genes in essential tremor. European Journal of Neurology 15, 889–890.CrossRefGoogle ScholarPubMed
167.Clark, LN and Louis, ED (2015) Challenges in essential tremor genetics. Revue Neurologique (Paris) 171, 466–474.CrossRefGoogle ScholarPubMed